Literature DB >> 1809043

Rapidly progressive renal failure associated with angiofollicular lymph node hyperplasia.

Y Tsukamoto1, N Hanada, Y Nomura, Y Hiki, K Kasai, H Shigematsu, Y Kobayashi.   

Abstract

The authors report a case of rapidly progressive renal failure associated with Castleman's disease. Renal biopsy revealed crescentic glomerulonephritis associated with marked tubulointerstitial nephritis. This kind of renal lesion has never been reported in association with angiofollicular lymph node hyperplasia (Castleman's disease) or other immunoblastic disorders. The patient initially required hemodialysis therapy. However, steroid therapy was effective in treating the systemic manifestations of Castleman's disease and some renal function was recovered. The patient was finally withdrawn from hemodialysis therapy.

Entities:  

Mesh:

Year:  1991        PMID: 1809043     DOI: 10.1159/000168351

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  5 in total

1.  Efficacy of tocilizumab, a humanized neutralizing antibody against interleukin-6 receptor, in progressive renal injury associated with Castleman's disease.

Authors:  Akito Maeshima; Masao Nakasatomi; Daizo Henmi; Shin Yamashita; Yoriaki Kaneko; Takashi Kuroiwa; Keiju Hiromura; Yoshihisa Nojima
Journal:  CEN Case Rep       Date:  2012-03-17

Review 2.  Emerging treatments in Castleman disease - a critical appraisal of siltuximab.

Authors:  Jean L Koff; Sagar Lonial
Journal:  Biologics       Date:  2016-01-25

3.  To and TAFRO - a cryptic cause of acute renal failure: a case report.

Authors:  N Shah; T Davidson; C Cheung; K Keung
Journal:  BMC Nephrol       Date:  2022-01-06       Impact factor: 2.388

4.  Successful treatment with tocilizumab for refractory anemia and slowly progressive renal glomerulosclerosis in multicentric Castleman disease: A case report.

Authors:  Eri Sugawara; Taiki Sato; Yoshiharu Amasaki; Kazuaki Katsumata
Journal:  Medicine (Baltimore)       Date:  2022-02-25       Impact factor: 1.817

5.  A rare case of renal thrombotic microangiopathy associated with Castleman's disease.

Authors:  Anubha Mutneja; L Nicholas Cossey; Helen Liapis; Ying Maggie Chen
Journal:  BMC Nephrol       Date:  2017-02-10       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.